maxsattana-istockphoto-com-plant-
maxsattana / iStockphoto.com
4 April 2017BiotechnologyJane Wainwright

Plants, patents and political challenges

Followers of the changing life sciences patenting landscape will be well aware of the extended saga at the European Patent Office (EPO) regarding two cases heard together and known as Broccoli and Tomatoes. In these cases the Enlarged Board of Appeal of the EPO decided that, while essentially biological processes of producing plants or animals (such as crossing of plants or sexual reproduction of animals) are excluded from patentability, new products derived from such processes are not excluded from patentability simply because they resulted from such an essentially biological process.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
22 October 2025   Chuck Scholtz, head of IP at Verdiva Bio, shares the pressures of global filing strategies on tight budgets, why there’s no ‘right way’ to manage IP, and how to get the best results from external counsel relationships.
Biotechnology
2 September 2025   Erik Viik of Papula-Nevinpat looks at the dynamics that international applicants need to be aware of to secure and manage their patent rights across the region.
Biotechnology
12 June 2025   Judges uphold PTAB’s finding that two Agilent patents are invalid | All claims of patents, which cover guide RNAs, found to be anticipated by prior art.